Skip to main content
. 2019 Oct 24;12:791–798. doi: 10.2147/CCID.S216222

Table 4.

Incidence Of Injection Site Responses In Any Treatment Area

n (%)a
Initial (n=131) Touch-Up (n=31) Initial + Touch-Up (n=131) Repeat (n=62)
Any ISR 130 (99.2) 28 (90.3) 130 (99.2) 54 (87.1)
ISR category
 Redness 127 (96.9) 18 (58.1) 127 (96.9) 53 (85.5)
 Swelling 121 (92.4) 15 (48.4) 122 (93.1) 44 (71.0)
 Tenderness to touch 118 (90.1) 16 (51.6) 118 (90.1) 45 (72.6)
 Bruising 114 (87.0) 11 (35.5) 114 (87.0) 46 (74.2)
 Firmness 114 (87.0) 13 (41.9) 115 (87.8) 43 (69.4)
 Lumps/bumps 112 (85.8) 11 (35.5) 112 (85.5) 42 (67.7)
 Pain after injection 107 (81.7) 7 (22.6) 107 (81.7) 42 (67.7)
 Itching 39 (29.8) 4 (12.9) 39 (29.8) 13 (21.0)
 Discoloration 38 (29.0) 2 (6.5) 40 (30.5) 16 (25.8)

Note: aDenominator is the number of subjects who recorded in diaries after the treatment.

Abbreviation: ISR, injection site response.